KLAC
59
3
VFC
56
11
NTRS
44
5
CNP
54
4
NWS
37
2
UA
33
7
PM
62
2
PBI
60
14
GPC
38
3
MAC
62
4
GE
82
5
DUK
69
5
RRC
46
-2
VRSK
56
16
GOOGL
50
2
FLR
48
6
PNW
69
2
ALLE
66
2
MLM
50
3
IR
65
2
KLAC
59
3
VFC
56
11
NTRS
44
5
CNP
54
4
NWS
37
2
UA
33
7
PM
62
2
PBI
60
14
GPC
38
3
MAC
62
4
GE
82
5
DUK
69
5
RRC
46
-2
VRSK
56
16
GOOGL
50
2
FLR
48
6
PNW
69
2
ALLE
66
2
MLM
50
3
IR
65
2
Financhill
Back

Syndax Pharmaceuticals Quote, Financials, Valuation and Earnings

How Banks Can Seize Your Accounts

Learn More
Sell
40

SNDX
Syndax Pharmaceuticals

Last Price:
18.14
Seasonality Move:
-8.74%

7 Day Trial

ALL ACCESS PASS

$ 7

32,481% Growth? Meet Mode Mobile's "EarnPhone"

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Syndax Pharmaceuticals Price Quote

$18.14
-0.98 (-5.13%)
(Updated: September 16, 2024 at 3:35 PM ET)

Syndax Pharmaceuticals Key Stats

Sell
40
Syndax Pharmaceuticals (SNDX) is a Sell
Day range:
$18.15 - $19.33
52-week range:
$11.22 - $25.34
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
3.75%
Volume:
807.6K
Avg. volume:
922.8K
1-year change:
12.4%
Market cap:
$1.6B
Revenue:
$0
EPS:
$-3.38

How Much Does Syndax Pharmaceuticals Make?

Data Unavailable

Is Syndax Pharmaceuticals Growing As A Company?

Data Unavailable

Syndax Pharmaceuticals Stock Price Performance

What Is Syndax Pharmaceuticals 52-Week High & Low?

Syndax Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Syndax Pharmaceuticals?

Is Syndax Pharmaceuticals Cash Flow Positive?

  • What Is SNDX Cash Flow From Operations?
    Cash flow from operations (TTM) is -$241.2M
  • What Is Syndax Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $263.2M
  • What Is Syndax Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$13.9M

Syndax Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    SNDX return on invested capital is -58.96%
  • What Is Syndax Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is -53.6%
  • What Is SNDX Return On Equity?
    ROE is a measure of profitability and is -58.96%

Syndax Pharmaceuticals Earnings Date & Stock Price

Syndax Pharmaceuticals Competitors

Syndax Pharmaceuticals Dividend Yield

Syndax Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 12.17%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 8
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 35.15
Upside from Last Price: 83.86%

Major Shareholders

  • How many SNDX shares are owned by institutional investors?
    121.9M SNDX shares are owned by institutional investors
  • How many SNDX shares are owned by insiders?
    812.3K SNDX shares are owned by insiders